Patient empowerment and risk–assessment to improve outcome in the elderly after gastrointestinal, thoracic or urogenital cancer surgery - Pilot study
- Conditions
- elderly patients with cancerPerioperative riskassessment and long-term outcome after onco-surgeryC51C68C15-C26C30-C39Malignant neoplasm of vulvaMalignant neoplasm of other and unspecified urinary organsMalignant neoplasms of digestive organsMalignant neoplasms of respiratory and intrathoracic organs
- Registration Number
- DRKS00005150
- Lead Sponsor
- niv-Klinik für Anästhesiologie m. S. operative Intensivmedizin,Campus Virchow-Klinikum und Charité Mitte, Charité Universitätsmedizin Berlin
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 145
Inclusion Criteria
•Written informed consent by the patient
•Patients aged = 65 years with gastrointestinal (upper gastrointestinal, colorectal), thoracic and urogenital (prostate gland, uterine) malignancies scheduled for surgery
•Mini Mental State > 23
•Life-expectance > 2 months
Exclusion Criteria
•No informed consent by the patient
•Failure to obtain consent
•Emergent patients
•Outpatients,
•Participation in another clinical study
•Patients with concurrent malignancies
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mortality (deceased/ not deceased) and Quality of life (EORTC-QLQ C30 Questionnaire) one year after surgery
- Secondary Outcome Measures
Name Time Method 1. short-term morbidity (postoperative complications,measured with the Clavien Scale)<br>2. Length of hospital stay
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What biomarkers correlate with improved long-term survival in elderly patients post-onco-surgery for digestive, respiratory, or urogenital cancers?
How does patient empowerment influence postoperative complication rates in elderly cancer surgery populations compared to standard care?
What molecular pathways are associated with perioperative risk stratification in gastrointestinal, thoracic, and urogenital malignancies?
Are there geriatric-specific biomarkers predictive of adverse events after cancer surgery in the PERATECS observational framework?
What risk-assessment tools are validated for predicting postoperative outcomes in elderly patients with C15-C26, C30-C39, or vulvar malignancies?